TCF7L2型
单核苷酸多态性
肝移植
糖尿病
医学
内科学
基因型
胃肠病学
人口
等位基因
他克莫司
移植
内分泌学
遗传学
生物
基因
环境卫生
作者
Qi Ling,Haiyang Xie,Di Lu,Xuyong Wei,Feng Gao,Lin Zhou,Xiao Xu,Shusen Zheng
标识
DOI:10.1016/j.jhep.2012.09.025
摘要
Backgrounds & Aims
New-onset diabetes mellitus (NODM) is a frequent and serious complication arising after liver transplantation (LT). Transcription factor 7-like 2 (TCF7L2) polymorphisms have been reported to strongly associate with type 2 diabetes. In addition, the donor liver plays a vital role in regulating blood glucose levels. In this study, we aim at evaluating the association between donor and recipient TCF7L2 gene polymorphisms with NODM after LT. Methods
A total of 125 patients undergoing primary LT, without a history of diabetes were included. Four single nucleotide polymorphisms (rs290487, rs7903146, rs11196205, and rs12255372), closely associated with type 2 diabetes in the Eastern Asia population, were genotyped and analyzed. Results
Both donor and recipient rs290487 polymorphisms (CC vs. TT genotype) were found to be significantly associated with NODM. In multivariate analysis, donor rs290487 genetic variation (OR=2.172 per each C allele, p=0.015), blood tacrolimus levels at 1month post-LT >10ng/ml (OR=3.264, p=0.017), and recipient age >55years (OR=2.638, p=0.043) were identified as independent risk factors of NODM. Furthermore, donor rs290487 CC genotype could predict a high probability (>40%) of the onset of NODM. Predictive model containing donor rs290487 polymorphism showed a significantly higher prognostic ability on NODM than the model with only clinical parameters (p=0.031). Conclusions
Donor TCF7L2 rs290487 polymorphism is associated with an increased risk of NODM after LT and has a potential clinical value for the prediction of NODM.
科研通智能强力驱动
Strongly Powered by AbleSci AI